Affiliation: University of Mainz
Glaffig M, Palitzsch B, Stergiou N, SchÃ¼ll C, Strassburger D, Schmitt E, et al
. Enhanced immunogenicity of multivalent MUC1 glycopeptide antitumour vaccines based on hyperbranched polymers. Org Biomol Chem. 2015;13:10150-4 pubmed publisher
Palitzsch B, Gaidzik N, Stergiou N, Stahn S, Hartmann S, Gerlitzki B, et al
. A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic Cancer. Angew Chem Int Ed Engl. 2016;55:2894-8 pubmed publisher
..We synthesized MUC1-glycopeptide vaccines and analyzed their structure-activity relationships in immunizations; a monoclonal antibody that specifically distinguishes between human normal and tumor epithelial cells was thus generated. ..
Shi L, Cai H, Huang Z, Sun Z, Chen Y, Zhao Y, et al
. Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern Bearing R/S-configured Pam3 CysSerLys4. Chembiochem. 2016;17:1412-5 pubmed publisher